RT @SatejaParadkar: Super excited to share that my first first-author publication is out today and we made the cover of @Oncotarget! Thankf…
RT @SatejaParadkar: Super excited to share that my first first-author publication is out today and we made the cover of @Oncotarget! Thankf…
Creation of a new class of radiosensitizers for glioblastoma based on the mibefradil pharmacophore - https://t.co/gGGTnl4rWk
"Creation of a new class of #radiosensitizers for #glioblastoma based on the #mibefradil pharmacophore." Read the full cover paper: https://t.co/wOADLUSyee https://t.co/BXclAuXEEY
Watch the #OncotargetShort video about this week's cover paper. Read the full study: https://t.co/wOADLUSyee #radiosensitizers #glioblastoma #medEd #cancerresearch #oncology https://t.co/E5s9RgekEc
The cover paper chosen for this week's new issue of Oncotarget is a study that details the creation of a new class of #radiosensitizers for #glioblastoma, based on the #mibefradil pharmacophore. Read the study: https://t.co/wOADLUSyee
RT @SatejaParadkar: Super excited to share that my first first-author publication is out today and we made the cover of @Oncotarget! Thankf…
Congratulations @SatejaParadkar on this exciting work!!
RT @SatejaParadkar: Super excited to share that my first first-author publication is out today and we made the cover of @Oncotarget! Thankf…
RT @SatejaParadkar: Super excited to share that my first first-author publication is out today and we made the cover of @Oncotarget! Thankf…
RT @SatejaParadkar: Super excited to share that my first first-author publication is out today and we made the cover of @Oncotarget! Thankf…
RT @SatejaParadkar: Super excited to share that my first first-author publication is out today and we made the cover of @Oncotarget! Thankf…
Great work by @SatejaParadkar @ranjitbindra establishing a new class of mibefradil-based DNA repair inhibitors with potential to become GBM radiosensitizers!! @YaleCancer
Check out this study by @SatejaParadkar from Bindra lab!
RT @Oncotarget: The cover of Oncotarget's latest issue features Figure 6: "Identification of potential regulators of the selective alt-NHEJ…
Super excited to share that my first first-author publication is out today and we made the cover of @Oncotarget! Thankful to my incredible mentor @ranjitbindra and to Dr. Surovtseva and to all my brilliant co-authors! https://t.co/73dcdmlluI
The cover of Oncotarget's latest issue features Figure 6: "Identification of potential regulators of the selective alt-NHEJ inhibition of mibefradil," by Paradkar, et al. https://t.co/wOADLUSyee